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1 INTRODUCTION 
 
1.1 Endothelium and its barrier function 
 
The endothelium is located at the interface between blood and the vessel wall. The 
cells are in close contact and form a monolayer that prevents blood cell interaction 
with the vessel wall as blood moves through the vessel lumen. Dependent on its 
localization in the vessel tree it forms a multifunctional signal-transducing surface and 
also serves as a barrier to the transvascular exchange of liquids and solutes. 
Endothelial cells (EC) modulate the tone of vascular smooth muscle cells (VSM), 
which in turn controls blood pressure and blood flow by adjusting the calibre of 
arteries and arterioles. In the microvascular bed, EC regulate the permeation of 
various metabolites, macromolecules and gases, as well as autocrine and paracrine 
factors and are involved in the regulation of cell nutrition. In all vessel types, EC are 
involved in blood coagulation, control of the transport between blood and tissue, 
movement of cells adhering to EC, wound healing, and angiogenesis. Other functions 
require an active response of EC to various signals of mechanical, chemical, or 
neuronal nature and origin. Some of these signals originate from cells of other origin, 
which are in contact to endothelial cells (vascular smooth muscle cells), or may 
originate from adhering cells (leukocytes or thrombocytes) or neighbouring 
endothelial cells. This signal transduction is impaired during certain 
pathophysiological conditions like ischemia and the subsequent reperfusion. 
An essential requirement for adequate organ performance is the formation of 
permeability barriers that separate and maintain compartments of distinctive structure. 
The barrier function of endothelium regulates the transport of fluids and molecules 
between blood and interstitial space, largely through small intercellular pores. Actin-
myosin filaments stabilise the form of the endothelial cells, and thereby also regulate 
the size of intercellular pores. In pathological conditions, such as ischemia and 
reperfusion, endothelial cell retract markedly and lose attachment to each other. This 
facilitates fluid and protein diffusion into the interstitium causing tissue swelling 
known as edema.  
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1.2 The role of Ca2+ in vascular endothelial cells during ischemia and reperfusion 
 
Many EC functions depend on cytosolic Ca2+. When metabolically impaired, 
endothelial cells react with a change in cytosolic Ca2+ concentration. Even a moderate 
reduction of cytosolic ATP, i.e., for 30 % leads to a pronounced increase in cytosolic 
Ca2+ in endothelial cells exposed to simulated ischemic conditions. (Noll et al. 1995, 
Schäfer et al. 2001). When functions of ATP-dependent ionic pumps are altered, 
calcium and sodium accumulate in the cell, due to their impaired extrusion.  
During simulated ischemia, the endothelial cells react with a biphasic increase in 
cytosolic Ca2+. A first rise of cytosolic Ca2+ is due to the release of Ca2+ through IP3 
sensitive Ca2+ channels of the endoplasmic reticulum (Ladilov et al. 2000, Schäfer et 
al. 2001). After the initial increase, the Ca2+ concentration rises further due to a 
secondary, “capacitative” Ca2+ entry from the extracellular space (Adams et al. 1989, 
Putney 1990, Dolor et al. 1992, Berridge 1995, Schäfer et al. 2001). Elevated 
cytosolic Ca2+ leads to formation of intercellular gaps. Gap formation causes a change 
in endothelial barrier permeability and leads to edema in vivo. This is especially 
noticeable in a reperfusion phase following ischemia.  
Gap formation is triggered by the following mechanism: Ca2+ overload during 
ischemia-reperfusion stimulates an activation of the contractile apparatus of 
endothelial cells. Cell-cell contacts (tight junctions, adherence junctions) are also 
destabilised (Muhs et al. 1997, Schäfer et al. 2003). As a consequence, endothelial 
cells detach from each other. On the molecular level, contractile activation is due to 
the activation of the Ca2+-calmodulin dependent myosin light chain kinase leading to 
an increase in myosin light chain-phosphorylation (Garcia et al. 1997). 
 
1.3 The role of KATP channels in modulation of Ca2+ influx during ischemia and 
reperfusion 
 
Ca2+ entry in EC occurs via different pathways, but the activation mechanisms of 
these entry pathways are still elusive. EC not only activate Ca2+ entry upon ischemia 
and reperfusion, but also provide a sufficiently large inwardly driving force for Ca2+. 
There is evidence that a Na+/Ca2+ exchanger (NCX) may  shape Ca2+ transients 
activated by vasoactive agonists (Teubl et al. 1999) and it has been also shown that a 
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reduction of the Na+ gradient increases Ca2+ via NCX in reverse mode operation 
(Sedova et al. 1999). Nilius et al. (2001) indicated that the driving force for Ca2+ entry 
is mainly tuned by channels that modulate electrogenesis in EC and used the 
following formula from Adams et al. (1993) for calculating Ca2+ influx (JCa): 
 
JCa=2 x N x F x p x γCa x (VM-ECa) 
 
where F is the Faraday constant, N is the number of channels, p is the open 
probability of the channel and γCa is its conductance. Ca2+ entry is regulated by the 
driving force for Ca2+, i.e., the difference between membrane potential (VM) and 
equilibrium potential for Ca2+ (ECa). Based on this formula, Ca2+ influx increases with 
plasmalemma hyperpolarisation. In an intact cell this may be antagonised by an 
increase in plasmalemma Ca2+ pump activity and Ca2+ extrusion via the NCX in 
forward mode operation favoured by a larger membrane potential. 
Electrogenesis in EC is regulated by K+ channels, but other channels, for example Cl- 
channels may be involved (Nilius et al. 2001). In endothelial cells Kamouchi et al. 
(1999), have demonstrated that increase in K+ channel activity and the resulting 
plasmalemma hyperpolarisation causes an increase in Ca2+ influx, as it increases the 
driving force for Ca2+ influx across the plasmalemma. Langheinrich et al. (1998) 
showed in endothelial capillaries that low concentrations of the KATP channels opener 
diazoxide induce a rapid, transient rise of cytosolic Ca2+ followed by a further 
sustained elevation. In an in vitro analysis of the role of KATP channels in hypoxia-
anoxia in three distinct neuronal systems of rodents, Ballanyi et al. (2004) 
demonstrated that in dorsal vagal neurons, inhibition of KATP channels with 
sulfonylureas abolishes the hypoxic-anoxic hyperpolarisation which is accompanied 
by a moderate and sustained increase of intracellular Ca2. 
Under physiologic conditions KATP channels are inhibited, since their open-state is 
dependent on the cytosolic ATP level. Therefore KATP channels do not seem to play a 
role in regulation of the K+ homeostasis under normal physiological circumstances. 
However, during ischemia the cytosolic level of ATP decreases more than 30 %, 
which leads to activation of the KATP channels. The role of KATP channels in Ca2+ 
overload of vascular endothelial cells under conditions of ischemia-reperfusion was in 
the focus of this study. 
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1.4 Molecular structure of KATP channels and their role in ischemia and 
reperfusion 
 
KATP channels consist of an octameric complex containing two distinct types of 
protein subunits, four of which are inwardly rectifying potassium channels subunits 
(Kir6.1 or Kir6.2). Each Kir subunit is associated with a larger regulatory 
sulphonylurea receptor (SUR). The molecular diversity of the KATP channels among 
species and tissue types is further expanded by the presence of multiple isoforms of 
SUR (SUR1, SUR2A, SUR2B). The SUR1 isoform is present in pancreatic KATP 
channels while the SUR2A and SUR2B isoforms are present in cardiac and vascular 
KATP channels. The structure of the KATP channels in vascular endothelium is to date 
not clarified. Immunohistological data from cardiac cryosections suggest Kir6.1 
protein is expressed in ventricular myocytes, as well as in smooth muscle and 
endothelial cells of coronary vessels and endothelial capillaries. Kir6.2 protein 
expression is found predominantly in ventricular myocytes and also in endothelial 
cells. SUR1 subunits are not expressed in the coronary vasculature, whereas SUR2 is 
predominantly localised in cardiac myocytes and coronary vessels, mostly in smaller 
vessels (Morrissey et al. 2005). 
KATP channels are characterised by dependence of their activation on the 
concentrations of intracellular ATP, ADP and other nucleotides (Yamada et al. 1997, 
Gribble et al. 1998). KATP channels can be activated pharmacologically by a 
chemically heterogeneous class of compounds, or KATP channel openers, and can be 
blocked by sulfonylurea derivatives. Reduction in cytosolic level of ATP during 
ischemia leads to activation of the KATP channels which enables their role in 
electrogenesis and thus taking a part in modulating the driving force for Ca2+ entry 
during ischemia. Unless the above named compensatory mechanisms prevail, KATP 
channels opening would therefore contribute to the extent of ischemic endothelial 
Ca2+ overload. It may then be expected that inhibition of KATP channels during 
ischemia could also decrease the development of cytosolic Ca2+ overload. Its 
reduction could decrease the level of contractile apparatus activation and thus the 
formation of intercellular gaps, which serve as parameters for cellular injury during 
ischemia and reperfusion. Inhibition of KATP channels during ischemia and 
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reperfusion could be used as a clinical target for prevention of endothelial barrier 
function failure. 
 
1.5 Aim of the study 
 
The main focus of this study on endothelial cells exposed to conditions of simulated 
ischemia and reperfusion was based on the following questions: 
 
-Does activation of KATP channels during ischemia and reperfusion take place? 
 
-Are KATP channels involved in the increase of cytosolic Ca2+ during ischemia and 
reperfusion? 
 
-What influence do KATP channels have on formation of intercellular gaps? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 10
2 MATERIALS: 
 
2.1 Chemicals: 
 
BAPTA 
(1,2-bis(o-aminophenoxy)ethane- 
N,N,N',N'-tetraacetic acid)    Sigma-Aldrich, Taufkirchen 
 
BSA  
(Bovine Serum Albumin)    Sigma-Aldrich, Taufkirchen 
 
Carbogen O2/CO2=95 %/5 % (vol/vol)  Messer Griesheim, Krefeld 
 
Collagenase Type CLS II (322 U/mg)   Biochrom KG, Berlin 
 
Cystein      Sigma-Aldrich, Taufkirchen 
 
Diazoxide       
(7-Chloro-3-methyl-2H-1,2,4-benzothiadiazine 
1,1-dioxide)      Sigma-Aldrich, Taufkirchen 
 
DiBAC4(3)  
bis-(1,3-dibutylbarbituric acid)     
trimethine oxonol     Invitrogen, Karlsruhe 
 
DMSO  
(Dimethyl Sulfoxide)                Merck, Darmstadt 
 
EDTA       
(ethylenediaminetetraacetic acid)   Roth, Karlsruhe 
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EGTA 
ethylene glycol bis(2-aminoethyl ether)-   
N,N,N'N'-tetraacetic acid    Sigma-Aldrich, Taufkirchen 
  
Fura-2 AM      Invitrogen, Karlsruhe 
      
FCS  
(Fetal Calve Serum)     FAA Laboratories, Cölbe 
 
Glybenclamide      Sigma-Aldrich, Taufkirchen 
 
HEPES  
(4-(2-hydroxyethyl)-1- 
-piperazineethanesulfonic acid)                        Roche Diagnostics, Mannheim
       
HMR1098      Sanofi-Aventis, Frankfurt 
 
Medium199®      Biochrom, Berlin  
 
N2                   Messer Griesheim, Krefeld  
 
NaCN                 Merck, Darmstadt 
 
Ionomycin      Calbiochem, Bad Soden 
 
KCN       Merck, Darmstadt 
 
Penicillin/Streptomycin    Biochrom, Berlin 
 
Resazurin      Sigma-Aldrich, Taufkirchen 
 
Trypsin-EDTA     Invitrogen, Karlsruhe 
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2.2 Buffers 
 
2.2.1 Buffers for cell cultivation 
 
 
 
Standard Mixture 
 
Medium199® 9.8 g/l 
HEPES 36 g/l 
pH adjusted to 7.4 at 30 °C 
 
 
 
Medium for cell cultivation 
 
Medium199®/CO2
FCS 20 % (vol/vol) 
Penicillin/Streptomycin 5 % (vol/vol) 
pH adjusted to 7.4 at 5 % (vol/vol)CO2
 
 
 
Loading Buffer 
 
Medium199®/ HEPES 
FCS 2 % 
 
 
 
All Buffers were sterile and stored at 4 °C. 
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2.2.2 Perfusion buffers 
 
For the investigations several Perfusion Buffers were used. Their composition (in 
mM) is described bellow: 
 
 
Normoxic HEPES-buffered Tyrode Buffer - pH adjusted to 7.4 at 30 °C 
 
NaCl 135 
KCl 2.6 
KH2PO4 1.2 
MgSO4 1.2 
CaCl2 1.3 
HEPES 25 
 
 
Anoxic HEPES buffered Tyrode Buffer – pH adjusted to 6.4 at 30 °C 
 
NaCl 135 
KCl 2.6 
KH2PO4 1.2 
MgSO4 1.2 
CaCl2 1.3 
HEPES 25 
 
Media were autoclaved in accordance with the method of Allshire et al. (1987). 
Before autoclaving, resazurin (1 % vol/vol) and cystein (5 mM) were added to the 
medium, which was then equilibrated with N2, until a change in the colour of the 
medium appeared from violet to pink indicating a reduction of pO2. Subsequently, the 
medium was autoclaved at 2 bars for 40 minutes after which the medium turned 
colourless indicating a pO2<16 µPa. 
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3 METHODS 
 
3.1 Isolation of coronary microvascular endothelial cells 
 
Coronary microvascular endothelial cells were isolated from male Wistar rats which 
weighed approximately 200-300 g. The animals were bred in the experimental animal 
facility of the Institute of Physiology and had free access to the standard feed 
(Altromin) and had an unlimited access to water. 
The coronary microvascular endothelial cells were isolated according to the method 
of Piper at al. (1982). 
The following solutions were used: 
 
 
Powell Medium (in mM) – pH adjusted to 7.4 by treating with carbogen 
 
NaCl 110 
NaHCO3 25 
KCl 2.6 
KH2PO4 1.2 
MgSO4 1.2 
Glucose 11 
 
 
Plating Medium 
 
 
Medium199®/CO2
FCS 20 %  
Penicillin/Streptomycin 4 % 
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The animals were anaesthetised with ether and were euthanized by cervical 
dislocation. Subsequently, the thorax was opened, the pericardium, heart and lungs 
were surgically removed from the thoracic cavity simultaneously, and were 
immediately placed into an ice-cold isotonic NaCl solution. The tissue surrounding 
the heart was removed and discarded. The heart and its aorta were then attached to a 
Langendorff apparatus. To remove the remaining blood from the coronary blood 
vessels the heart was perfused with Powell medium (20 ml) for approximately two 
minutes. The tissue was perfused with the collagenase buffer (2-3 ml/min), for 30 
minutes. During the perfusion, the medium was constantly warmed to a temperature 
of 37 °C and gassed with carbogen. At the end of the recirculating perfusion, the heart 
was removed from the Langendorff apparatus below the atria and was then 
mechanically minced. 
The tissue was incubated for five minutes in recirculation buffer (37 oC) and gassed 
with carbogen. The dissociation of the endothelial cells was performed in this solution 
by pipetting up and down of the cell solution with a 5 ml pipette. The next step was 
filtration of the cell suspension through a nylon mesh (pore size 0,2 mm), in order to 
separate the remaining cell aggregates. The filtrate was then separated into two 50 ml 
Falcon tubes and then centrifuged at 25 x g for 3 minutes. The supernatant covering 
the cardiomyocite pellet was removed and then covered with trypsin and calcium. 
After two additional centrifugation steps the heart cell suspension was plated onto 10 
cm cell culture plates and incubated with CO2 for 4 hours. After incubation, the 
endothelial cells were washed and then covered with 30 ml medium for cell 
cultivation; medium was changed every 48 hours. After 7 days the cells became 
confluent and could be trypsinized. Prior to trypsinization, the cells were washed 
several times with Ca2+-free HEPES-buffered Tyrode-buffer in order to remove the 
dead cells and other cellular debris. An additional advantage of this step is that Ca2+ 
was removed from the cell-cell communications sites and the sites between the cells, 
which simplifies the trypsinization. Subsequently, 5 ml of trypsin at 37 °C was added 
to the cells for 10 minutes. The cells were then pipetted up and down with a 1 ml 
pipette to break up any large clumps of cells. The solution was subsequently mixed 
with 125 ml plating medium (prewarmed to 37 °C) and the cell suspension was split 
into a series of 30 mm diameter culture dishes each containing a 25 mm diameter 
coverslip. This procedure was performed under sterile conditions and all the 
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instruments used in this process were previously sterilised. Three days later, a 
confluent monolayer of endothelial cells that had grown on the coverslip could be 
used for experiments; the number of cells on a coverslip was on average 2x105 
cells/cm2. 
 
3.2 Fluorescent microscopy measurements for determination of cytosolic Ca2+ 
concentration.  
 
Experiments were performed with an inverse microscope, which was connected to the 
Till-Vision System. The excitation light sent from the UV-lamp can be modulated to 
the excitation spectrum of the Fura-2 AM fluorescent dye with the use of a 
monochromator. The selected wavelengths are 340, 360 and 380 nm for Fura-2 AM. 
The light is directed to a dichroic filter through a fiber optic cable. The dichroic filter 
then directs the light to the chamber with the loaded cell. Through this, the fura-2 AM 
is excited and the excitation light is directed through the dichroic filter, which then 
only lets light with a certain wavelength to pass through to the CCD-Camera. From 
there the image was detected and analysed on a computer. 
 
 
 
 
 
 
 
 
 
 
Objective 
            UV-Lamp                  Monochromator                            Dichroid-Filter               CCD-Camera         Computer Software        
Heating Perfusion chamber
Pump 
Reservoir 
 
 
Fig.1 Graphic presentation of the experimental setup for measurement of cytosolic Ca2+ 
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3.2.1 Cell loading with Fura-2 AM and calibration of the signal 
 
In order to determine the intracellular Ca2+ concentration, the cells were loaded for 90 
minutes at room temperature with the fluorescent dye Fura-2 AM (2,5 µM) in HEPES 
buffered Medium 199. Fura-2 AM enters the cell as an acetoxymethylester where it is 
split by cellular esterases, thereby preventing it from permeating the cell membrane 
again and leaving the cell. The excitation of Fura-2 AM is done every 6 seconds with 
a wavelength of 340, 360 and 380 nm. The maximum emission was at 510 nm. The 
wavelength at 360 nm is the wavelenth where the fluorescence signal is independent 
of the Ca2+ concentration. For determination of the Ca2+ load, the ratio (R) between 
the wavelengths of 340 nm and 380 nm was used. (340 nm/380 nm). The free 
cytosolic Ca2+ concentration can be determined according to the following equation 
(Grynkiewicz at al. 1985): 
 
[Ca2+]I =Kd x b x (R-Rmin)/(Rmax-R) 
 
Factor b is the ratio of the emission intensity at the excitation wavelength of 380 nm, 
corresponding to the Rmin value and the emission intensity at the excitation 
wavelength of 380 nm, corresponding to the Rmax value. The Kd value is a value for 
the affinity of the Fura-2 AM for free cytosolic Ca2+ ions. This value varies with the 
experimental conditions and is dependent on pH. Under in vitro conditions the Kd 
value of Fura-2 AM is 224 nM (Grynkiewicz et al. 1985). In vivo, Ladilov et al. 
(2000) determined a Kd value of 309 ± 8 nM (n=6) at intracellular pH 7.2, and a Kd 
value of 347 ± 7 nM (n=5) at intracellular pH 6.5. 
For determination of the cytosolic Ca2+ concentration, the Fura-2 Ratio was calibrated 
with the Kd values determined by Ladilov et al. (2000). 
 
 
 
 
 
 
 
 18
Calibration solution 
NaCl 10 mM 
KCl 125 mM 
MgSO4 1 mM 
HEPES 25 mM 
Ionomycin 5 µM 
CaCl2 or EGTA 3 mM or 5 mM 
BAPTA 10 µM 
pH adjusted to 7.4 with 1N KOH 
 
For determination of the Rmax value (maximal ratio), 3M CaCl2 was added to the 
perfusate, and for the determination of the Rmin value (minimal ratio) 5 mM EGTA 
and 10 µM BAPTA were added to the perfusate. 
 
3.2.2 Determination of the size of intercellular gaps.  
 
In order to determine the formation of intercellular gaps it was necessary to determine 
a wavelength by which the fluorescent signal is independent of the intracellular Ca2+ 
concentration. Therefore the spectrum of wavelengths was measured at high and low 
Ca2+ concentrations and the appropriate wavelength was determined when the 
intensity of the signal did not change. The isosbestic value, or the value where the 
emission intensity of Fura-2 AM is independent of the Ca2+ concentration, is 360 nm. 
The original sequence was binarized, i.e. pixels with Fura-2 AM emission 
intensity were set to “1”, whereas pixels without emission intensity were set to “0”. 
Pixels marked with “0” represent cell-free area (no emission intensity), whereas pixels 
marked with “1” represent cell-covered areas (emission intensity). These conditions 
were introduced to the software programme (Till Imago), which then calculates “1” 
pixels and “0” pixels. The region for intercellular gap determination was chosen in 
such a manner that at the very beginning of the experiment the size of the intercellular 
gaps was 6000-8000 pixels. (0). This value increased typically after 40 minutes of 
ischemia (pH 6.4) to 45000-55000 pixels. During reperfusion intercellular gaps 
increase further and with it the number of the pixels whose value was determined to 
be 0. With this procedure it is possible to determine the increase of intercellular gaps 
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compared to the size of the cells. For the analysis the number of 0 pixels during 10 
minutes of normoxia at the beginning of the experiment was set to 100 %. The change 
in the size of the intercellular gaps during ischemia and reperfusion was then 
expressed as a percent compared to the normoxic value. 
 
3.3 Determination of membrane potential with the fluorescent dye DiBAC4(3) 
 
The fluorescent dye DiBAC4(3), used for the measurement of membrane potential, 
binds to cellular and membrane proteins, where during hyperpolarisation of the cell 
membrane the dye leaves the cell and the fluorescence decreases. The dye enters 
depolarised cells, where it binds to the hydrophobic sites of intracellular proteins or 
membranes, and exhibits enhanced fluorescence and red spectral shifts. Increased 
depolarisation results in more influx of the anionic dye that binds to proteins resulting 
in increase in fluorescence. Conversely, hyperpolarisation is indicated by a decrease 
in fluorescence. The cells were loaded with DiBAC4(3) (1 µM) in a normoxic 
perfusion medium for 15 minutes and then used for ischemia and reperfusion 
experiments. The excitation wavelength of DiBAC4(3) is 484 nm, and the emission 
wavelength is 520 nm. Potential-dependent fluorescence changes generated by 
DiBAC4(3) are typically ~1 % per 1 mV (Scott et al. 2004). 
 
3.4 Equipment 
 
The cells were introduced into a gas tight perfusion chamber. The perfusion chamber 
has the same diameter as the coverslip and has two additional rubber rings. The rings 
limit the possibility that air can get into the chamber and prevent the coverslip from 
breaking while the perfusion chamber is assembled. The chamber is assembled by 
tightly screwing the upper part to the lower part. In this manner the monolayer in the 
chamber can be anoxically perfused using stainless steel capillaries connecting the 
perfusion chamber to bottles filled with normoxic or anoxic medium. A peristaltic 
pump attached to the chamber limits the flow of the medium through the perfusion 
system to a velocity of 0.5 ml/min.  
The normoxic medium was aerated before and during the experiments with air, and 
the anoxic medium with N2 (100 %). The temperature in the perfusion chamber was 
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adjusted to 30 °C. The partial O2 pressure in the anoxic medium was determined with 
a polarographic Oxygen sensor directly behind the perfusion chamber and its value 
was less than 1 mmHg. 
 
3.5 Experimental Protocol 
 
The experimental protocol was set in a manner to simulate ischemia and reperfusion. 
All experiments started after a 10 minutes long equilibration phase in normoxic 
medium at pH of 7.4 without glucose. In order to simulate ischemia and reperfusion, 
the cells were then perfused for 40 minutes with an anoxic HEPES buffered tyrode 
buffer (p02<16 µPa), glucose free and with a pH of 6.4. Subsequently, the cells were 
reoxygenated for 30 minutes with a medium at pH of 7.4 and with 2.5 mM glucose. 
Pharmacological opening of KATP channels was performed with diazoxide (1 µM). 
During ischemia and reperfusion KATP channels were inhibited with two chemically 
distinct sulphonylurea derivatives: glybenclamide (10 µM; Fig.2) or HMR1098 (100 
µM; Fig.3). While glybenclamide also shows inhibitory effects in ß -cell plasma-
membrane KATP channels, recent advances in sulphonylurea chemistry have lead to 
development of tissue specific plasmalemmal KATP channel inhibitors like HMR1098 
which displays selectivity for the cardiac versus ß -cell plasma-membrane KATP 
channels (Gögelein et al. 1999, Hu et al. 1999). 
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Fig.2 Chemical structure of Glybenclamide 
 
 
 
 
Fig.3 Chemical structure of HMR1098 
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3.6 Interventions in the protocol: 
 
Normoxia Ischemia Reperfusion 
 
 
 
10 min. 50 min. 80 min. 0 min. 40 min. 30 min. 20 min. 
 
 
 
Control Control Control 
 
 
 
 
 
 
 
 
 
 
 
 
 
Glybenclamide 
10 µM 
Glybenclamide 
10 µM 
Glybenclamide 
10 µM 
ControlControl Glybenclamide 
10 µM 
 
HMR1098 
100 µM 
HMR1098 
100 µM
HMR1098 
100 µM 
 
 
 
 
Control Control HMR1098 
100 µM 
 
 
 
 
 
 
 
 
 
 
 
 
 
Glybenclamide 
10 µM 
Glybenclamide 
10 µM
Control
Control Control
HMR1098 
100 µM 
 Control HMR1098 
100 µM
 
 
 
 
 
Ca2+-free
 
Ca2+-free Ca2+-free
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3.7 Statistical analysis 
 
The data are presented as mean values ± SEM. The statistical analysis was performed 
by one-way ANOVA and use of the Student-Newman-Keuls-Test for post-hoc 
analysis (Ludbrook, 1994). The p-values p ≤ 0.05 were considered as statistically 
significant. 
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4 RESULTS 
 
4.1 Effects of pharmacological opening and subsequent inhibition of KATP 
channels on membrane potential and cytosolic Ca2+ load 
 
The aim was to determine the concentration that would induce membrane 
hyperpolarisation through the opening of KATP channels. Experiments were performed 
using the KATP channel opener diazoxide in a concentration dependent manner. Fig.4 
shows a representative single-cell measurement of membrane potential with 
DiBAC4(3). DiBAC fluorescence is shown in relative terms, where a downward 
direction indicates hyperpolarisation, and an upward direction indicates 
depolarisation. The KATP channel opener diazoxide was added after 10 minutes of 
normoxic perfusion in concentrations of 0.1 µM or 1 µM. While perfusion with 0.1 
µM of diazoxide had no effect, perfusion with 1 µM induced a sustained 
hyperpolarisation of the plasmalemma. 
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Fig.4 Representative single-cell measurement of DiBAC Fluorescence (%) during 50 minutes 
of normoxic perfusion with diazoxide (0.1 µM and 1 µM). Diazoxide was added after 10 
minutes of perfusion. 
 
The next step was to investigate the optimal concentration of the KATP channel 
inhibitors, which would reduce the diazoxide induced hyperpolarisation of the 
plasmalemma. Two KATP channel inhibitors, glybenclamide and HMR1098 were 
tested. Concentrations of 0.1 µM for glybenclamide (76.9 %; SEM 2.4 %), and 10 µM 
for HMR1098 (85.3 %; SEM 2.3 %) did not inhibit the diazoxide induced 
hyperpolarisation of the plasmalemma. 10 µM of Glybenclamide and 100 µM of 
HMR1098 were required to reverse the diazoxide induced hyperpolarisation of the 
plasmalemma. The results of a series of experiments are shown in Fig.5: 
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Fig.5 DiBAC fluorescence (%) at the end of 50 minutes normoxic perfusion compared to 
control. Cells were perfused with 1 µM diazoxide, and with glybenclamide (10 µM) or 
HMR1098 (100 µM). *P<0.05 vs. control; #P<0.05 vs. diazoxide 1 µM. Data are presented as 
mean value ± SEM; (n=160 cells from 6 experiments). 
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The next experiment was to determine if the diazoxide induced hyperpolarisation of 
the plasmalemma influences the cytosolic Ca2+ load of the endothelial monolayers. 
After initial 10 minutes of normoxic perfusion, the cells were perfused with the KATP 
channel opener diazoxide (1 µM) and simultaneously perfused with different 
concentrations of the KATP channel inhibitors glybenclamide or HMR1098. Perfusion 
of the coronary endothelial monolayers with glybenclamide at a concentration of 0.1 
µM or HMR1098 at a concentration of 10 µM did not inhibit the diazoxide induced 
Ca2+ overload. Concentrations of 10 µM for glybenclamide and 100 µM for 
HMR1098 were required to reduce the diazoxide-induced Ca2+ overload. The 
statistical analysis of two subsequent series of experiments is presented in Figures 6 
and 7: 
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Fig.6 Fura-2 Ratio (a.u.) after 50 minutes of normoxic perfusion with 1 µM diazoxide, and 
simultaneous perfusion with diazoxide and different concentrations of glybenclamide (0.1 µM 
or 10 µM). Diazoxide and glybenclamide were added after 10 minutes from beginning of 
experiments. *P<0.05 vs. control; #P<0.05 vs. diazoxide 1 µM; n.s. (not significant) vs. 
diazoxide 1 µM. Data are presented as mean value ± SEM; (n=160 cells from 6 experiments). 
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Fig.7 Fura-2 Ratio (a.u.) after 50 minutes of normoxic perfusion with 1 µM diazoxide, and 
simultaneous perfusion with diazoxide (1 µM) and different concentrations of HMR1098 (10 
µM or 100 µM). Diazoxide and HMR1098 were added after 10 minutes of perfusion. #P<0.05 
vs. diazoxide 1 µM; *P<0.05 vs. control; n.s. (not significant) vs. diazoxide 1 µM. Data are 
presented as mean value ± SEM; (n=160 cells from 6 experiments). 
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4.2 Influence of ischemia and reperfusion on membrane potential 
 
Figure 8 shows a representative single-cell measurement of membrane potential with 
DiBAC4(3) during ischemia and reperfusion in absence or presence of glybenclamide 
(10 µM). During ischemia, there is a decrease of DiBAC4(3) fluorescence indicating a 
hyperpolarisation of the plasmalemma. The DiBAC4(3) fluorescence returns to a 
normoxic level during reperfusion conditions, indicating a repolarisation. When the 
cell was perfused with glybenclamide, the ischemia-induced hyperpolarisation was 
reduced. In reperfusion, the membrane potential returns to normoxic level and is not 
different from control conditions.  
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Fig.8 Single-cell measurement of DiBAC Fluorescence during ischemia and reperfusion 
under control conditions (dashed line) and under perfusion with glybenclamide (10 µM). 
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4.3 Influence of ischemia and reperfusion on cytosolic Ca2+ load and intercellular 
gap formation 
 
Figure 9 shows a representative measurement of the Fura-2 Ratio. In the first 10 
minutes of equilibration there is no increase in the cytosolic Ca2+ concentration. 
During the following 40 minutes of ischemic perfusion of the cells, a biphasic 
increase in cytosolic Ca2+ takes place. The first peak, which lasts approximately 10 
minutes after onset of ischemia, is caused by the release of Ca2+ from the 
endoplasmatic reticulum. The next, more gradual increase is caused by entry of Ca2+ 
from the extracellular space (Adams et al. 1989, Putney 1990, Dolor et al. 1992, 
Ladilov et al. 2000, Schäfer et al. 2001). Ischemia was followed by reperfusion. 
During this phase, the cytosolic Ca2+ concentration increases further. 
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Fig.9 Representative single-cell recording of Fura-2 Ratio (a.u.). First 10 minutes are 
normoxic perfusion, the subsequent 40 minutes are ischemic perfusion, followed by 30 
minutes reperfusion.  
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The other parameter measured was the formation and increase of intercellular gaps. 
Figure 10 shows a representative intercellular gap measurement during ischemia and 
reperfusion. The gaps begin forming with the onset of ischemia, and they further 
increase in reperfusion. It is important to notice that the increase of intercellular gaps 
is larger during reperfusion compared to ischemia. Intercellular gap formation was 
analysed as a percent of the normoxic level. The increase in intercellular gap 
formation reaches approximately 100 % at end of ischemia, and increases by 
additional 100 % in the next 30 minutes of reperfusion. 
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Fig.10 Analysis of intercellular gap formation during ischemia and reperfusion from a single 
experiment. During the first 10 minutes of normoxia there is no increase of intercellular gaps. 
The following 40 minutes of ischemia induce an intercellular gap increase of approximately 
100 % and further 100 % increase during the subsequent reperfusion. 
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4.4 Influence of extracellular Ca2+ influx on the initial Ca2+ release during 
ischemia and reperfusion. 
 
Cytosolic Ca2+ release during ischemia and reperfusion is characterised by a biphasic 
rise. The first, steep release is due to Ca2+ release from the endoplasmatic reticulum. 
After the initial rise, cytosolic Ca2+ rises further, due to Ca2+ influx from the 
extracellular space. However, when coronary microvascular endothelial cells are 
perfused under Ca2+-free conditions, besides the expected reduction of the second 
Ca2+ increase during ischemia there is also reduction of the initial Ca2+ release. The 
results of a series of experiments where endothelial monolayers were perfused under 
Ca2+-free conditions are showed in Fig.11. 
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Fig.11 Time course of Fura-2 Ratio (a.u.) during ischemia under control conditions and under 
Ca2+-free perfusion. Data are presented as mean value ± SEM; (n=160 cells from 6 
experiments). *P<0.05 vs. ischemia. 
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4.5 Membrane potential of coronary endothelial cells during ischemia and 
reperfusion and the role of KATP channels  
 
The membrane potential of the coronary microvascular endothelial cells was 
measured using the fluorescent dye DiBAC4(3) (Fig.12). The statistical analysis of 
experiments during control conditions shows a reduction in hyperpolarisation during 
ischemia when cells were perfused with glybenclamide and HMR1098 throughout the 
entire experiment. During reperfusion, the DiBAC4(3) fluorescence returns to 
normoxic value. 
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Fig.12 DiBAC4(3) Fluorescence (in % compared to normoxic control), after 40 min. ischemia 
with or without HMR 1098 or glybenclamide and after 30 min. reperfusion with or without 
HMR1098 or glybenclamide. Data are presented as mean value ± SEM; (n=160 cells from 6 
experiments). *P<0.05 vs. normoxia; #P<0.05 vs. ischemia; n.s. (not significant) vs. 
reperfusion. 
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4.6 Influence of KATP channels on cytosolic Ca2+ load during ischemia and 
reperfusion 
 
To investigate the influence of KATP channels on the Ca2+ homeostasis of endothelial 
monolayers, the KATP channel inhibitor glybenclamide was used at concentration of 
10 μM. The microvascular coronary endothelial monolayers were perfused with 
glybenclamide during the whole experiment. In the presence of glybenclamide the 
fura-2 Ratio was reduced, indicating a reduction of ischemia-induced cytosolic Ca2+ 
overload (Fig.13a). 
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Fig.13a Time course of Fura-2 Ratio (a.u.) during ischemia and reperfusion under control 
conditions and under perfusion with glybenclamide (10 µM) throughout the entire 
experiment. Data are presented as mean value ± SEM; (n=160 cells from 6 experiments); 
*P<0.05 vs. control. 
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There is also a clear reduction formation of intercellular gaps in experiments in which 
the cells were perfused with glybenclamide compared to control experiments 
(Fig.13b). 
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Fig.13b Time course of intercellular gap formation during ischemia and reperfusion under 
control conditions and under perfusion with glybenclamide (10 µM) throughout the entire 
experiment. Data are presented as mean values ± SEM; (n=160 cells from 6 experiments); 
*P<0.05 vs. control. 
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A chemically distinct KATP channel inhibitor, HMR1098, was used to further confirm 
that the plasmalemmal KATP channels influence the Ca2+ load during ischemia and 
reperfusion: HMR1098 acts specifically on the plasmalemmal KATP channels. 
HMR1098 was used in concentration of 100 μM and the cells were also perfused with 
HMR1098 during the whole experiment. Figure 14a shows the influence of 
HMR1098 on the cytosolic Ca2+ load during ischemia and reperfusion compared to 
control experiments. 
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Fig.14a Time course of Fura-2 Ratio (a.u.) during ischemia and reperfusion under control 
conditions and under perfusion with HMR1098 (100 µM). Data are presented as mean value ± 
SEM; (n=160 cells from 6 experiments); *P<0.05 vs. control. 
 
 
 
 
 
 
 37
When the formation and increase of intercellular gaps was analysed, similar results 
were observed. Namely, there is a clear reduction in the increase of intercellular gaps 
in the experiments in which the endothelial monolayers were perfused with 
HMR1098, compared to control experiments (Fig.14b). 
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Fig.14b Time course of intercellular gap formation during ischemia and reperfusion under 
control conditions and under perfusion with HMR1098 (100 µM). Data are presented as mean 
value ± SEM; (n=160 cells from 6 experiments); *P<0.05 vs. control. 
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4.7 Influence of KATP channel inhibitors on the initial Ca2+ release during 
simulated ischemia 
 
The perfusion of the endothelial monolayers with the KATP channel inhibitors 
glybenclamide or HMR1098 was performed from the beginning of ischemia and 
reperfusion. As the results of the previous experiments show, both glybenclamide and 
HMR1098 reduce the initial Ca2+ rise during ischemia. In order to investigate if KATP 
channel inhibitors also influence the initial Ca2+ rise during ischemia, experiments 
were performed in which coronary microvascular endothelial monolayers were treated 
with glybenclamide or HMR1098 from the time point the initial Ca2+ release can no 
longer be pharmacologically influenced. In ischemia and reperfusion experiments, 
this was minute twelve of ischemia. In these experiments the initial Ca2+ rise was 
unaltered. The second Ca2+ increase, however is reduced in presence of KATP channel 
inhibitors. Parallel to the Ca2+ measurements, analysis of intercellular gap formation 
was also performed. The results of the planimetric analysis of the performed 
experiments revealed a clear reduction of intercellular gap formation during ischemia 
and reperfusion, when glybenclamide or HMR1098 were added from the twelfth 
minute of ischemia. Figures 15a and 15b show the statistical analysis, where the 
influence of glybenclamide on cytosolic Ca2+ (Fig. 15a), and on formation of 
intercellular gaps (Fig. 15b) was analysed, where the endothelial monolayers were 
perfused with glybenclamide from the peak of the initial Ca2+ release during ischemia 
until end of experiments. 
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Fig.15a Time course of Fura-2 Ratio (a.u.) during ischemia and reperfusion under control 
conditions, and under perfusion with glybenclamide added from the twelfth minute of 
ischemia. Data are presented as mean value ± SEM; (n=160 cells from 6 experiments); 
*P<0.05 vs. control. 
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Fig.15b Time course of gap intercellular formation during ischemia and reperfusion under 
control conditions, and under perfusion with glybenclamide added at the twelfth minute of 
ischemia. Data are presented as mean value ± SEM; (n=160 cells from 6 experiments); 
*P<0.05 vs. control. 
 
Experiments were also performed where the coronary microvascular endothelial 
monolayers treated with the chemically distinct KATP channel inhibitor, HMR1098. In 
this series of experiments HMR1098 was also added from the twelfth minute of 
ischemia. The results further confirm that KATP channel inhibitors influence the initial 
Ca2+ release during ischemia. Fig.16a shows the statistical analysis where the 
influence of HMR1098 on the cytosolic Ca2+ (Fura-2 Ratio) was investigated when 
HMR1098 was added from the twelfth minute of ischemia.  
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Fig.16a Time course of Fura-2 Ratio (a.u.) during ischemia and reperfusion under control 
conditions, and under perfusion with HMR1098 added at the twelfth minute of ischemia. Data 
are presented as mean value ± SEM; (n=160 cells from 6 experiments); *P<0.05 vs. control. 
 
The analysis of intercellular gap formation also showed that perfusion of coronary 
microvascular endothelial monolayers with HMR1098 from the twelfth minute of 
ischemia until end of experiments reduce formation of intercellular gaps during 
ischemia and reperfusion (Fig.16b). 
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Fig.16b Time course of intercellular gap formation during ischemia and reperfusion under 
control conditions, and under perfusion with HMR1098 added at the twelfth minute of 
ischemia. Data are presented as mean value ± SEM; (n=160 cells from 6 experiments); 
*P<0.05 vs. control. 
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4.8 Influence of KATP channels on Ca2+ load and intercellular gap formation 
during reperfusion  
 
The influence of the KATP channels on cytosolic Ca2+ load and intercellular gap 
formation in coronary microvascular endothelial cells was investigated with onset of 
reperfusion. The results do not show a statistically significant difference between the 
Fura-2 Ratio of control experiments and experiments in which endothelial monolayers 
were perfused with glybenclamide (Fig.17a). 
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Fig.17a Time course of Fura-2 Ratio (a.u.) during ischemia and reperfusion, under control 
conditions, and under perfusion with glybenclamide (10 µM) only during reperfusion. Data 
are presented as mean value ± SEM; (n=160 cells from 6 experiments); n.s. (not significant) 
vs. control. 
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When the influence of the KATP channels on formation of intercellular gaps was 
investigated during reperfusion, again no significant difference was observed between 
control experiments and experiments where the endothelial monolayers were perfused 
with glybenclamide in reperfusion (Fig.17b). 
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Fig.17b Time course of intercellular gap formation during ischemia and reperfusion under 
control conditions, and under perfusion with glybenclamide (10 µM) only during reperfusion. 
Data are presented as mean value ± SEM; (n=160 cells from 6 experiments); n.s. (not 
significant) vs. control. 
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Figure 18a shows the results from a series of experiments where the influence of the 
plasmalemmal KATP channels on cytosolic Ca2+ was studied when HMR 1098 was 
applied only during reperfusion. The results did not show a reduction in the Ca2+ load 
in reperfusion when the cells were treated with HMR1098 compared to control 
conditions. 
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Fig.18a Time course of Fura-2 Ratio (a.u.) during ischemia and reperfusion under control 
conditions, and under perfusion with HMR1098 only during reperfusion. Data are presented 
as mean value ± SEM; (n=160 cells from 6 experiments); n.s. (not significant) vs. control. 
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When the formation of intercellular gaps was analysed, there was no significant 
reduction in intercellular gap formation under perfusion with HMR 1098 compared to 
control conditions (Fig. 18b). 
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Fig.18b Time course of intercellular gap formation during ischemia and reperfusion under 
control conditions and under perfusion of cells with HMR1098 (100 µM) only during 
reperfusion. Data are presented as mean value ± SEM; (n=160 cells from 6 experiments); n.s. 
(not significant) vs. control.  
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5 DISCUSSION 
 
The present study investigated the role of KATP channels on Ca2+ overload and 
barrier function on microvascular coronary endothelial cells under ischemia and 
reperfusion. The findings of this study show that ischemic conditions cause opening 
of plasmalemmal KATP channels and membrane hyperpolarisation. This KATP channel 
opening contributes to the progressive influx of Ca2+ into endothelial cells, the 
formation of intercellular gaps and hence, to failure of barrier function of endothelial 
monolayers under ischemic conditions. In reperfusion, KATP channels do not influence 
Ca2+ overload or barrier function. 
Under normoxic conditions KATP channels are normally in a closed state and 
do not take part in the regulation of cellular ion homeostasis, since cytosolic levels of 
ATP inhibit their activation. Under normoxic conditions, application of a 
pharmacological KATP channel opener may therefore exert a pronounced effect. E.g., 
Langheinrich et al. (1997) found a glybenclamide-sensitive hyperpolarisation induced 
by KATP channels openers and glucose deprivation in capillaries isolated from guinea 
pig hearts. Some results of the present study are in agreement with those findings. 
Pharmacological activation of the KATP channels with use of diazoxide induced a 
sustained hyperpolarisation of the cell membrane in a dose-dependent manner. 
Application of the KATP channels inhibitors glybenclamide or the chemically distinct 
inhibitor HMR1098 abolished the diazoxide-induced hyperpolarisation of normoxic 
cells. 
Exposure of endothelial cells to ischemia caused a change in their membrane 
potential, in form of a hyperpolarisation. When endothelial monolayers were treated 
with the KATP channel inhibitor glybenclamide, the hyperpolarisation of the 
plasmalemma was significantly reduced. Treatment of the endothelial monolayers 
with the chemically distinct KATP channel inhibitor HMR1098 confirmed this 
observation. This indicates that ischemic hyperpolarisation in endothelial cells is 
caused by opening of plasmalemmal KATP channels. The most likely cause is that 
ischemic conditions cause ATP depletion, and this then leads to activation of KATP 
channels. During 30 minutes of reperfusion following ischemic conditions the 
membrane potential returned to normoxic levels. Neither treatment with 
glybenclamide nor with HMR1098 influenced the membrane potential during 
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reperfusion. This might be expected, since a rise in cytosolic ATP concentration 
during reperfusion, caused by metabolic recovery, inhibits KATP channels. 
Normoxic experiments on endothelial cells demonstrated that 
hyperpolarisation of the plasmalemma induced by pharmacological KATP channel 
opening is accompanied by a Ca2+ influx into the cell. This finding is in agreement 
with previous studies (Lückhoff et al. 1990, Nilius et al.1991, Kamouchi et al. 1997, 
Chen et al. 2001, Adams et al. 2004). Langheinrich et al. (1998) showed in coronary 
capillary EC that low concentrations of the KATP channel openers diazoxide and 
rilmakalim cause a pronounced glybenclamide-sensitive hyperpolarisation and induce 
a rapid Ca2+ transient followed by a sustained elevation of cytosolic Ca2+. 
The results of the present study revealed that KATP channels also contribute to 
the regulation of the Ca2+ homeostasis in EC during ischemic conditions. Treatment 
with KATP channel inhibitors glybenclamide or HMR1098 from onset of ischemic 
conditions to the end of reperfusion reduced the Ca2+ overload during ischemia and 
reperfusion. The basic features of changes in Ca2+ homeostasis under ischemia and 
reperfusion were previously described (Noll et al. 1995, Ladilov et al. 2000, Schäfer 
et al. 2001): Coronary EC develop a biphasic Ca2+ overload during ischemia, an initial 
rise mainly due to Ca2+ release from the ER and a secondary rise due to Ca2+ influx 
from the extracellular space. When applied from onset of ischemia, KATP channel 
inhibitors reduced the initial rise of cytosolic Ca2+. Our Ca2+-free experiments also 
showed a reduction of the first rise. This observation indicates that the first Ca2+ rise 
contains a part of Ca2+ influx from the extracellular space. This extracellular influx 
component is dependent on plasmalemmal KATP channels, probably by their effect on 
the rapidly developing hyperpolarisation.  
To test the effect of KATP opening on the delayed Ca2+-influx, glybenclamide 
or HMR1098 was applied at the peak of the initial Ca2+ rise. It was found that this 
postponed application of the KATP channel inhibitors still reduced the secondary Ca2+ 
increase during ischemia. It can therefore be concluded that KATP opening and 
plasmalemma hyperpolarisation also promotes the secondary Ca2+ influx during 
ischemia. It is likely that store-operated Ca2+ entry (SOC) is the mechanism that 
propagates the delayed Ca2+ influx into the cell (Adams et al. 1989, Putney 1990, 
Dolor et al. 1992, Berridge et al. 1995, Nilius et al. 2001). One may also discuss if 
activation of the NCX in reverse mode (influx of Ca2+ and efflux of Na+) contributes 
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to ischemic endothelial Ca2+ overload. Reverse mode of NCX can be triggered by 
accumulation of cytosolic Na+ and plasmalemma depolarisation. Na+ accumulation 
may occur when the Na, K-ATPase fails due to a lack of energy. Berna et al. (2001) 
hypothesised a mechanism in endothelial cells, by which glycolysis during ischemia 
leads to a pronounced influx of Na+ and consequently to activation of NCX in its 
reverse mode, resulting in net influx of Ca2+. The finding, that ischemic conditions in 
endothelial cells lead to a prominent hyperpolarisation, makes it unlikely, however, 
that NCX is activated under these conditions since a reverse mode of activation of 
NCX is favoured by membrane depolarisation. 
The pharmacological reduction of the Ca2+ overload during ischemia and 
reperfusion with the KATP channel inhibitors leads to reduction of endothelial barrier 
failure developing under these conditions. This was expected since it was previously 
shown that cytosolic Ca2+ overload during ischemia and reperfusion can trigger the 
failure of the endothelial barrier (Schäfer et al. 2003). The underlying cause exists in 
activation of the Ca2+-calmodulin dependent myosin light chain kinase (MLCK). 
Phosphorylation of MLCK results in stress fiber formation, cell contraction and 
subsequent formation of intercellular gaps (Sheldon et al. 1993, Garcia et al. 1995).  
The failure of the KATP channel inhibitors glybenclamide or HMR1098 to 
influence reperfusion-induced Ca2+ overload, as shown in this study, suggests that 
KATP channels are not involved in the mechanism causing the Ca2+ rise in the 
reperfusion phase following ischemia. Peters et al. (2007) demonstrated that 
reoxygenation-induced Ca2+ overload in endothelial cells is due to a Ca2+ influx. It is 
probably secondary to another activation of the InsP3 receptor of the ER and 
activation of store-operated Ca2+ channels of the plasmalemma. 
In summary, the following scheme can be proposed for the mechanism of 
reduction of endothelial barrier failure through inhibition of plasmalemmal KATP 
channels under ischemic conditions: 
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Fig.19 Proposed mechanism of action of plasmalemmal KATP channels during ischemia 
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ATP depletion during ischemia causes KATP channels to switch to an open state. This 
activation leads to a K+ efflux, which then induces hyperpolarisation of the 
plasmalemma. The hyperpolarisation in turn increases the driving force for influx of 
Ca2+ into the cytosol, having as consequence a Ca2+ overload. The Ca2+ overload then 
activates the cellular contractile apparatus resulting in formation of intercellular gaps 
and barrier dysfunction (Schäfer et al. 2003). Reduction of the Ca2+ overload during 
ischemia through inhibition of plasmalemmal KATP channels reduces the Ca2+ 
overload. Concomitantly, less intercellular gaps are formed, and the endothelial 
barrier remains relatively stable.  
When the heart is considered as a whole the evidence for inhibition of KATP 
channels as protective principle is mixed, dependent on cell type and subcellular 
location of the KATP channel under investigation. Many studies have shown that 
opening rather than inhibition of KATP channels during ischemia is cardioprotective on 
the heart as a whole. It has also been shown that the effect of KATP channels opening 
mimics the protective effect of preconditioning, a phenomenon in which brief periods 
of ischaemia produce a phenotype in the heart and other organs in which the tissue is 
protected against the deleterious consequences of a subsequent more prolonged period 
of ischemia (Murry et al. 1986). Preconditioning produces a marked reduction in 
myocardial infarct size, and one of the central triggers and mediators is the opening of 
the mitochondrial KATP channels (Garlid et al. 1997, O'Rourke, 2000), whereas 
opening of plasmalemmal KATP channels during ischemia does not exert this 
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protective effect (Saavedra et al. 2002). In endothelial cells, Wang et al. (2007) have 
hypothesized that activation of endothelial KATP channels could reduce endothelial 
dysfunction. Their findings suggested that the activation of endothelial KATP channels 
activates endothelial NO synthase and inhibits the release and synthesis of endothelin-
1 However, even in the area of global cardioprotection not all data indicate activation 
of KATP channels is protective. In an in vivo study by Picard et al. (1998) using 
perfused guinea pig hearts it was shown that application of KATP channel openers 
increases the amount of membrane damage in the cell, where application of gliburide, 
a KATP channel inhibitor, reduced it. A further important finding in this study was the 
proarrythmic effect of KATP channel opening. 
Activation of the myocardial sarcolemmal KATP channels by ischemia, or by 
application of pharmacological agents causes shortening of the action potential 
duration thereby predisposing the heart to reentrant arrhythmias (Janse et al. 1989, 
Wilde et al. 1990). Kääb et al. (2003) demonstrated that HMR1098 is useful to 
prevent KATP channel-induced shortening of the action potential in human ventricular 
myocardium. This is explained by the fact that opening of KATP channels during 
ischemia or with pharmacological agents leads to efflux of K+ which in turn shortens 
the duration of action potential. As a consequence, the refractory period is reduced, 
and this renders the myocardium more vulnerable to re-entry mechanisms and, as a 
consequence, ventricular fibrillation. More acidic conditions as observed in ischemia 
increase the sensitivity to HMR1098, indicating a more potent effect in ischemic 
myocardium. Thus, HMR1098 may be a useful agent to prevent action potential 
shortening and dispersion of repolarisation during ischemia, which may protect 
against ischemia induced ventricular arrhythmias. 
 Another area of interest in terms of cardioprotection is cardiac transplantation 
when hearts are deprived of blood supply for few hours. Progress in development of 
cardioplegic solutions has not completely eliminated the underlying challenges of 
ischemia and reperfusion. Methods for preservation and storage, developed initially to 
protect cardiomyocyte function, may be deleterious for vascular endothelium. The 
impairment of endothelial barrier function results in perivascular and tissue edema 
and this promotes graft dysfunction. The use of KATP channel inhibitors added to 
cardioplegic solutions may represent a promissing adjuvant to cardioprotective 
solutions in surgery.  
 52
Based on the above mentioned mechanisms of action of KATP channels during 
ischemia, the following scheme can be proposed about the potential use and 
development of pharmacological agents in cardioprotection having KATP channels as 
pharmacological targets: 
 
 
 
 
 
 
 
 
 
 
 
 
      
 
 
 
 
    
 
 
 
 
 
 
 
endothelial cells 
plasmalemmal mitochondrial 
cardiomyocytes cardiomyocytes 
KATP channel opening
Ischemia
           protective           unfavourable       unfavourable                 protective   
                       (NO production)       (barrier failure)       (arrythmogenic)       (reduction of infarct size)   
 
The focus of future research of ischemic cardioprotection should be 
development of pharmacological agents that selectively block plasmalemmal KATP 
channels, due to their protective action both on endothelial cells as well as on 
cardiomyocytes. The results of this study may contribute to identifying new strategies 
which by including endothelium-protective effects would improve cardiac protection. 
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6 SUMMARY: 
 
The aim of the present study was to investigate the role of the KATP channels on 
induction of the ischemia-reperfusion injury in coronary microvascular endothelial 
cells. 
The main findings of this study are: 
 
• Ischemia induces activation of the KATP channels in coronary microvascular 
endothelial cells. 
 
• Activation of KATP channels during ischemia induces hyperpolarisation of the 
plasmalemma. 
 
• Hyperpolarisation of the plasmalemma during ischemia is accompanied by a 
Ca2+ influx. 
 
• Inhibition of the KATP channels during ischemia with glybenclamide or 
HMR1098 reduces the hyperpolarisation of the plasmalemma and the Ca2+ 
influx. 
 
• Inhibition of the KATP channels during ischemia reduces the formation of 
intercellular gaps. 
 
• Inhibition of the KATP channels during reperfusion does not influence the 
membrane potential or the Ca2+ load, nor does it influence the formation of 
intercellular gaps. 
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6 ZUSAMMENFASSUNG: 
 
Die Hauptaufgabe der vorliegenden Arbeit war zu klären, welche Bedeutung die  
KATP –Kanäle in koronaren Endothelzellmonolayern während simulierter Ischämie 
und Reperfusion haben. 
 
Die Befunde dieser Arbeit lauten wie folgt: 
 
• Ischämie führt zur Aktivierung der KATP-Kanäle in koronaren 
mikrovaskulären Endothelzellen. 
 
• Aktivierung der KATP-Kanäle während der Ischämie führt zur 
Hyperpolarisation der Zellmembran. 
 
• Die KATP-Kanal-induzierte Hyperpolarisation der Zellmembran während der 
Ischämie wird von mit einem Ca2+-Einstrom aus dem Extrazellulärraum 
begleitet. 
 
• Die Inhibierung der KATP-Kanäle während der Ischämie mit Glybenclamide 
oder HMR1098 reduziert die Hyperpolarisation der Zellmembran und den 
Ca2+-Einstrom. 
 
• Eine Inhibierung der KATP-Kanäle während der Ischämie reduziert die 
Entstehung der interzellulären Lücken. 
 
• Eine Inhibierung der KATP-Kanäle nur während der Reperfusion hat weder 
einen Einfluß auf das Membranpotential noch auf die Calciumhomöostase 
noch auf die Entstehung interzellulärer Lücken. 
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